ReviewCurrent neurology and neuroscience reports2013
Inclusion body myositis.
Review in Current neurology and neuroscience reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 64 citations in OpenAlex.
- Trial
- Case Report: Progressive interstitial lung disease secondary to Sjögren's disease in a patient with inclusion body myositis complicated by dysphagia-a multidisciplinary approach and therapeutic challenges.Frontiers in medicine · 2025Article
- Face to Face: deciphering facial involvement in inclusion body myositis.Journal of neurology · 2024Article
- Compound muscle action potential of whole-forearm flexors: A clinical biomarker for inclusion body myositis.Clinical neurophysiology practice · 2024Article
- Increasing daily duration of rehabilitation for inpatients with sporadic inclusion body myositis may contribute to improvement in activities of daily living: A nationwide database cohort study.Journal of rehabilitation medicine · 2023Article
- Electromyography varies by stage in inclusion body myositis.Frontiers in neurology · 2023Article
- Evidence of nerve hypertrophy in patients with inclusion body myositis on lower limb MRI.Muscle & nerve · 2022Article
- How Imaging Can Assist with Diagnosis and Monitoring of Disease in Myositis.Current rheumatology reports · 2020Review
- Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5.PloS one · 2020Article
- Review
- Association between TDP-43 and mitochondria in inclusion body myositis.Laboratory investigation; a journal of technical methods and pathology · 2019Article
- Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges.International journal of general medicine · 2019Review
- Update on Inclusion Body Myositis.Current rheumatology reports · 2018Review
- Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.Annals of the rheumatic diseases · 2016Article
- Targeting protein homeostasis in sporadic inclusion body myositis.Science translational medicine · 2016Article
- Hypokalemia-Induced Rhabdomyolysis by Primary Aldosteronism Coexistent With Sporadic Inclusion Body Myositis.Annals of rehabilitation medicine · 2015Article
- Misdiagnosis of inclusion body myositis: two case reports and a retrospective chart review.Journal of medical case reports · 2015Article
- Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.Journal of neuropathology and experimental neurology · 2015Article
- Ongoing developments in sporadic inclusion body myositis.Current rheumatology reports · 2014Review
- Sporadic inclusion body myositis: new insights and potential therapy.Current opinion in neurology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sporadic inclusion body myositis (IBM) is the most common idiopathic inflammatory myopathy (IIM) after age 50 years. It presents with chronic insidious proximal leg and distal arm asymmetric muscle weakness. Despite similarities with polymyositis (PM), it is likely that IBM is primarily a degenerative disorder rather than inflammatory muscle disease. IBM is associated with a modest degree of creatine kinase (CK) elevation and an electromyogram (EMG) demonstrates a chronic irritative myopathy. Muscle histopathology demonstrates endomysial inflammatory exudates surrounding and invading non-necrotic muscle fibers often times accompanied by rimmed vacuoles. We review IBM with emphasis on recent developments in the field and discuss ongoing clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.